Home / Tag Archives: Continuous Glucose Monitoring (page 2)

Tag Archives: Continuous Glucose Monitoring

Could CGM Help People With Type 1 Diabetes Live Longer?

Person with type 1 diabetes using a continuous glucose monitor and smartphone to track glucose levels.

Could continuous glucose monitoring do more than improve glucose levels and help prevent hypoglycemia? New research raises that possibility. A large observational study examining CGM use and mortality in people with type 1 diabetes found that starting continuous glucose monitoring was associated with a lower risk of death among older …

Read More »

When “Normal” Blood Sugar Feels Too Low: New Research May Explain Why

When glucose numbers improve, patients are expected to feel better. Yet some people with type 1 diabetes report the opposite. A glucose level that looks reassuring on a continuous glucose monitor may leave them feeling tired, uncomfortable, or simply “off.” New research suggests that glycemic habituation may help explain this …

Read More »

Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?

Patient with Type 2 diabetes using real-time CGM while receiving maintenance hemodialysis.

Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …

Read More »

Three Decades of Better Type 1 Diabetes Care: Have Complications Actually Declined?

Person with type 1 diabetes using modern glucose monitoring technology, illustrating advances in care and long-term complication prevention.

Three decades of advances in diabetes care have transformed how people with type 1 diabetes manage glucose. Insulin pumps, continuous glucose monitoring (CGM), improved insulin analogs, automated insulin delivery, and earlier screening have all changed daily treatment. However, have these advances actually reduced the long-term complications of type 1 diabetes? …

Read More »

Beyond A1C: Can CGM Help Prevent Severe Hypoglycemia and DKA?

Person using a continuous glucose monitor to track glucose levels and help prevent severe hypoglycemia and DKA.

Continuous glucose monitoring has changed how clinicians and people with diabetes think about glucose control. Yet the next question is more important than whether CGM improves A1C or Time in Range. Can it prevent events that send patients to the emergency department or hospital? Growing evidence suggests that CGM may …

Read More »

Years After Bariatric Surgery, Blood Sugar Can Crash Without Warning. Here’s Why.

Patient checking blood glucose after experiencing symptoms of post-bariatric hypoglycemia

Blood glucose may improve dramatically after metabolic or bariatric surgery. Yet, for some patients, a very different glucose problem develops months or years later. Post-bariatric hypoglycemia can cause sudden drops in blood glucose after meals, with symptoms ranging from sweating and tremor to confusion, seizures, or loss of consciousness. Because …

Read More »

It’s Not Just About Sleep: How Circadian Medicine Could Rewrite Diabetes Care

Circadian clock illustrating how sleep, light exposure, meal timing, activity, and diabetes treatment interact throughout the day and night.

Diabetes care has traditionally focused on what patients eat, how much they exercise, and which medications they use. However, a growing field adds another question: when do these things happen? Research into circadian medicine in diabetes care suggests that the body’s internal clock may influence insulin sensitivity, glucose tolerance, hormone …

Read More »

Diabetes Research Is Being Reinvented: Why Today’s Clinical Trials Look Nothing Like a Decade Ago

Modern diabetes clinical trials using continuous glucose monitoring, wearable technology, digital health data, and remote clinical research.

Modern diabetes clinical trials look very different from the tightly controlled, site-centered studies clinicians relied on a decade ago. Remote visits, continuous glucose monitoring, wearable sensors, digital data collection, and broader enrollment are changing how evidence is generated. Meanwhile, newer trial designs can make studies more flexible and potentially more …

Read More »

Can Bi-Hormonal Systems Finally Eliminate Severe Hypoglycemia?

dual-hormone-artificial-pancreas-severe-hypoglycemia

Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …

Read More »